<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurotherapeutics</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotherapeutics</journal-id>
<journal-title-group>
<journal-title>Neurotherapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1933-7213</issn>
<issn pub-type="epub">1878-7479</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30112700</article-id>
<article-id pub-id-type="pmc">6277296</article-id>
<article-id pub-id-type="publisher-id">657</article-id>
<article-id pub-id-type="doi">10.1007/s13311-018-0657-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function <italic>KCNT1</italic> Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Dilena</surname>
<given-names>Robertino</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>DiFrancesco</surname>
<given-names>Jacopo C.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Soldovieri</surname>
<given-names>Maria Virginia</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giacobbe</surname>
<given-names>Antonella</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ambrosino</surname>
<given-names>Paolo</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mosca</surname>
<given-names>Ilaria</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galli</surname>
<given-names>Maria Albina</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guez</surname>
<given-names>Sophie</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fumagalli</surname>
<given-names>Monica</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miceli</surname>
<given-names>Francesco</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cattaneo</surname>
<given-names>Dario</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Darra</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gennaro</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zara</surname>
<given-names>Federico</given-names>
</name>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Striano</surname>
<given-names>Pasquale</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Castellotti</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gellera</surname>
<given-names>Cinzia</given-names>
</name>
<xref ref-type="aff" rid="Aff10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Varesio</surname>
<given-names>Costanza</given-names>
</name>
<xref ref-type="aff" rid="Aff11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veggiotti</surname>
<given-names>Pierangelo</given-names>
</name>
<xref ref-type="aff" rid="Aff12">12</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8202-0560</contrib-id>
<name>
<surname>Taglialatela</surname>
<given-names>Maurizio</given-names>
</name>
<address>
<phone>+39-081-7463316</phone>
<email>mtaglial@unina.it</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff13">13</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1757 8749</institution-id><institution-id institution-id-type="GRID">grid.414818.0</institution-id><institution>Pediatric Epileptology and Neurophysiology (RD), Infantile Neuropsichiatry (AG), Cardiology (MAG), High Intensity Pediatric Care (SG), Neonatology (MF), </institution><institution>Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, </institution></institution-wrap>20122, Milan, Italy </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0707 5492</institution-id><institution-id institution-id-type="GRID">grid.417894.7</institution-id><institution>Clinical Neurophysiology and Epilepsy Center, </institution><institution>Fondazione IRCCS Istituto Neurologico Carlo Besta, </institution></institution-wrap>20133, Milan, Italy </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2174 1754</institution-id><institution-id institution-id-type="GRID">grid.7563.7</institution-id><institution>Department of Neurology, San Gerardo Hospital, School of Medicine and Surgery, Milan Center for Neuroscience (NeuroMi), </institution><institution>University of Milano-Bicocca, </institution></institution-wrap>20900, Monza, Italy </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000000122055422</institution-id><institution-id institution-id-type="GRID">grid.10373.36</institution-id><institution>Department of Medicine and Health Science, </institution><institution>University of Molise, </institution></institution-wrap>86100, Campobasso, Italy </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0790 385X</institution-id><institution-id institution-id-type="GRID">grid.4691.a</institution-id><institution>Division of Pharmacology, Department of Neuroscience, </institution><institution>University of Naples “Federico II”, </institution></institution-wrap>80131, Naples, Italy </aff>
<aff id="Aff6"><label>6</label>Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, 20157, Milan, Italy </aff>
<aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1763 1124</institution-id><institution-id institution-id-type="GRID">grid.5611.3</institution-id><institution>Department of Surgical, Odontostomatological, and Maternal-Infantile Sciences, </institution><institution>University of Verona, </institution></institution-wrap>37134, Verona, Italy </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1757 8650</institution-id><institution-id institution-id-type="GRID">grid.450697.9</institution-id><institution>Laboratory of Genetics, </institution><institution>E.O. Ospedali Galliera, </institution></institution-wrap>16128, Genoa, Italy </aff>
<aff id="Aff9"><label>9</label>Pediatric Neurology and Muscular Diseases Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, “G. Gaslini” Institute, 16147, Genoa, Italy </aff>
<aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0707 5492</institution-id><institution-id institution-id-type="GRID">grid.417894.7</institution-id><institution>Unit of Genetics of Neurodegenerative and Metabolic Diseases, </institution><institution>Fondazione IRCCS Istituto Neurologico Carlo Besta, </institution></institution-wrap>20133, Milan, Italy </aff>
<aff id="Aff11"><label>11</label>Department of Child Neurology and Psychiatry, “C. Mondino” National Neurological Institute, 27100, Pavia, Italy </aff>
<aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1757 2822</institution-id><institution-id institution-id-type="GRID">grid.4708.b</institution-id><institution>Department of Biomedical and Clinical Sciences, Children’s Hospital Vittore Buzzi, </institution><institution>University of Milan, and Pediatric Neurology, </institution></institution-wrap>20154, Milan, Italy </aff>
<aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0790 385X</institution-id><institution-id institution-id-type="GRID">grid.4691.a</institution-id><institution>Department of Neuroscience, </institution><institution>University of Naples “Federico II”, </institution></institution-wrap>Via Pansini 5, 80131 Naples, Italy </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>15</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>15</volume>
<issue>4</issue>
<fpage>1112</fpage>
<lpage>1126</lpage>
<permissions>
<copyright-statement>© The American Society for Experimental NeuroTherapeutics, Inc. 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Epilepsy of infancy with migrating focal seizures (EIMFS) is a rare early-onset developmental epileptic encephalopathy resistant to anti-epileptic drugs. The most common cause for EIMFS is a gain-of-function mutation in the <italic>KCNT1</italic> potassium channel gene, and treatment with the KCNT1 blocker quinidine has been suggested as a rational approach for seizure control in EIMFS patients. However, variable results on the clinical efficacy of quinidine have been reported. In the present study, we provide a detailed description of the clinical, genetic, <italic>in vitro</italic>, and <italic>in vivo</italic> electrophysiological profile and pharmacological responses to quinidine of 2 EIMFS unrelated patients with a heterozygous <italic>de novo KCNT1</italic> mutation: c.2849G&gt;A (p.R950Q) in patient 1 and c.2677G&gt;A (p.E893K) in patient 2. When expressed heterologously in CHO cells, KCNT1 channels carrying each variant showed gain-of-function effects, and were more effectively blocked by quinidine when compared to wild-type KCNT1 channels. On the basis of these <italic>in vitro</italic> results, add-on quinidine treatment was started at 3 and 16 months of age in patients 1 and 2, respectively. The results obtained reveal that quinidine significantly reduced seizure burden (by about 90%) and improved quality of life in both patients, but failed to normalize developmental milestones, which persisted as severely delayed. Based on the present experience, early quinidine intervention associated with heart monitoring and control of blood levels is among the critical factors for therapy effectiveness in EIMFS patients with KCNT1 gain-of-function mutations. Multicenter studies are needed to establish a consensus protocol for patient recruitment, quinidine treatment modalities, and outcome evaluation, to optimize clinical efficacy and reduce risks as well as variability associated to quinidine use in such severe developmental encephalopathy.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s13311-018-0657-9) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Key Words:</title>
<kwd>KCNT1</kwd>
<kwd>Developmental encephalopathy</kwd>
<kwd>Epilepsy of infancy with migrating focal seizures (EIMFS)</kwd>
<kwd>Quinidine</kwd>
<kwd>Therapeutic drug monitoring (TDM)</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002426</institution-id>
<institution>Fondazione Telethon</institution>
</institution-wrap>
</funding-source>
<award-id>GGP15113</award-id>
<principal-award-recipient>
<name>
<surname>Taglialatela</surname>
<given-names>Maurizio</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003196</institution-id>
<institution>Ministero della Salute</institution>
</institution-wrap>
</funding-source>
<award-id>Ricerca Finalizzata Giovani Ricercatori 2016 (Project GR-2016-2363337)</award-id>
<principal-award-recipient>
<name>
<surname>DiFrancesco</surname>
<given-names>Jacopo C.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003407</institution-id>
<institution>Ministero dell’Istruzione, dell’Università e della Ricerca</institution>
</institution-wrap>
</funding-source>
<award-id>Project Scientific Independence of Researchers 2014 RBSI1444EM</award-id>
<principal-award-recipient>
<name>
<surname>Miceli</surname>
<given-names>Francesco</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007195</institution-id>
<institution>Università degli Studi di Napoli Federico II</institution>
</institution-wrap>
</funding-source>
<award-id>Program STAR “Sostegno Territoriale alle Attività di Ricerca” (project number 6-CSP-UNINA-120)</award-id>
<principal-award-recipient>
<name>
<surname>Miceli</surname>
<given-names>Francesco</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The American Society for Experimental NeuroTherapeutics, Inc. 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>